Position in LKFT
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$3,567
-$1,773 QoQ
Shares Held
119
-33.1% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#61
of 78 holders
Holding Since
Jun 2020
17 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LKFT Over Time
Shares Held
Position Value (USD)
Derivatives in LKFT
reported options exposure · as of Mar 31, 2024CallValue
$379,960
CallShares
11,800
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026BARCLAYS PLC holds $1,706,140,734 across 455 Biotechnology names. LKFT ranks #345 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
733,274 | $364,239,192 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
256,192 | $159,745,957 | |
| 3 | IONS |
Ionis Pharmaceuticals Inc
|
1,603,136 | $127,112,653 | |
| 4 | ARGX |
Argenx SE
|
134,427 | $124,717,337 | |
| 5 | MRNA |
Moderna, Inc.
|
1,035,126 | $72,489,872 | |
| 6 | BBIO |
BridgeBio Pharma, Inc.
|
714,423 | $53,210,224 | |
| 7 | TGTX |
Tg Therapeutics, Inc.
|
957,848 | $52,624,168 | |
| 8 | DNTH |
Dianthus Therapeutics, Inc. /DE/
|
431,753 | $42,087,281 |
All Filings in LKFT
Export CSV
18 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,567 | 119 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $5,340 | 178 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $77,008 | 2,355 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $1,351,029 | 39,002 | Shares | Sole | 2026-03-31 | |
| 2025-06-30 | $1,124,329 | 40,169 | Shares | Sole | 2026-02-27 | |
| 2025-03-31 | $800,322 | 31,860 | Shares | Sole | 2026-03-17 | |
| 2024-12-31 | $22,852 | 831 | Shares | Sole | 2026-03-19 | |
| 2024-09-30 | $2,879 | 100 | Shares | Sole | 2026-03-31 | |
| 2024-03-31 | $379,960 | 11,800 | Call | Sole | 2026-03-24 | |
| 2023-12-31 | $483,735 | 11,900 | Call | Sole | 2026-03-24 | |
| 2023-09-30 | $822,290 | 23,800 | Call | Sole | 2026-03-26 | |
| 2023-09-30 | $214,210 | 6,200 | Shares | Sole | 2026-03-26 | |
| 2022-03-31 | $1,226,259 | 19,772 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $455,428 | 8,261 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $434,611 | 8,261 | Shares | Sole | 2021-11-09 | |
| 2021-06-30 | $569,100 | 8,261 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $637,303 | 8,267 | Shares | Sole | 2021-05-13 | |
| 2020-06-30 | $1,361,301 | 6,900 | Shares | Sole | 2020-08-12 | |
| No filing history on record for this holder in this stock. | ||||||